Abbott Laboratories (ABT) Research & Development (2009 - 2026)

Abbott Laboratories has disclosed Research & Development across 18 years of filings, most recently posting $892.0 million for Q2 2026.

• In Q2 2026, Research & Development rose 23.03% year-over-year to $892.0 million; the TTM figure through Jun 2026 stood at $3.2 billion (up 8.85% YoY), while the FY2025 annual figure was $2.9 billion, up 3.45% from the prior year.
• Research & Development came in at $892.0 million for Q2 2026 at Abbott Laboratories, up from $767.0 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $892.0 million in Q2 2026 to a low of $654.0 million in Q1 2023.
• Average Research & Development over 5 years is $726.3 million, with a median of $715.5 million recorded in 2023.
• Year-over-year, Research & Development declined 14.07% in 2023 and grew 23.03% in 2026.
• Over 5 years, Research & Development stood at $725.0 million in 2022, then retreated by 3.45% to $700.0 million in 2023, then rose by 7.0% to $749.0 million in 2024, then retreated by 1.87% to $735.0 million in 2025, then increased by 21.36% to $892.0 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $892.0 million in Q2 2026, $767.0 million in Q1 2026, and $735.0 million in Q4 2025.